+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNA Modified Pseudouridine Market - Global Forecast 2025-2030- Product Image
RNA Modified Pseudouridine Market - Global Forecast 2025-2030- Product Image
Sale

RNA Modified Pseudouridine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6146225
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

RNA-modified pseudouridine is redefining the landscape of RNA therapeutics and molecular research, unlocking new levels of stability, efficacy, and immunogenicity reduction across clinical and scientific applications. As leading organizations adapt to regulatory shifts and evolving supply chains, this market offers actionable insights and growth strategies for senior decision-makers in biotechnology, pharmaceuticals, and diagnostic industries.

Market Snapshot: RNA-Modified Pseudouridine Growth and Opportunity

The RNA-modified pseudouridine market is experiencing robust growth, fueled by its pivotal role in innovative RNA therapeutics, rapid-response vaccine development, and advanced molecular research. This expansion is underpinned by strong demand for high-purity modified nucleotides, continuous technology innovation in synthesis and delivery, and collaborative industry efforts to address supply chain and regulatory dynamics. Market trends indicate accelerating adoption as companies and research organizations prioritize investment in scalable production, quality control, and advanced analytics to maintain competitive advantage.

Scope & Segmentation

This comprehensive report offers deep analysis and forecasts for the RNA-modified pseudouridine market. Coverage spans applications, product types, end users, forms, purity grades, regions, and company profiles, providing a clear structure for strategic assessment.

  • Application Areas: Academic Research, Diagnostic Research, mRNA Therapeutics, mRNA Vaccines
  • Types: 1-Methylpseudouridine, Pseudouridine
  • End Users: Academic and Research Institutes, Contract Research Organizations, Pharmaceutical and Biotechnology Companies
  • Forms: Liquid, Powder
  • Purity Grades: Analytical Grade, HPLC Grade
  • Regions: Americas (including United States – California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Canada, Mexico, Brazil, Argentina), Europe, Middle East and Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Analyzed Companies: Maravai LifeSciences, Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, New England Biolabs, PerkinElmer, Bio-Techne, GenScript Biotech, Creative Biolabs

Key Takeaways for Senior Decision-Makers

  • RNA-modified pseudouridine is central to next-generation vaccine platforms and advanced therapeutics due to stability and reduced immune response profiles.
  • Strategic collaborations between reagent suppliers and contract research organizations are addressing the escalating demand for high-purity modified nucleotides and ensuring reliable scalability.
  • Innovations in lipid nanoparticle delivery and enzymatic synthesis methods have streamlined production cycles and supported agile pipeline development.
  • Regulatory bodies are offering expedited pathways for RNA therapies, leveraging lessons from emergency authorizations to remove traditional barriers.
  • Artificial intelligence and machine learning are enabling in silico optimization of sequence design, supporting precise clinical and research outcomes.
  • Pioneering companies and smaller innovators are redefining value through proprietary synthesis, regional partnerships, and niche service models.

Tariff Impact: Navigating the 2025 Supply Chain Landscape

The 2025 introduction of United States trade tariffs has significantly impacted RNA-modified pseudouridine supply chains. Import duties on specialty reagents and raw materials have prompted manufacturers to diversify supplier networks, invest in domestic capabilities, and relocate operations closer to end markets. Contract research organizations and biotech firms are securing longer-term supply agreements and forging regional alliances to minimize tariffs’ operational effects. Active industry dialogue is essential to balance trade objectives with the necessity of uninterrupted high-purity reagent access.

Research Methodology & Data Sources

This report combines secondary research—drawing from peer-reviewed literature, patents, regulatory documents, and industry white papers—with primary insights collected via structured interviews and targeted end-user surveys. Analytical approaches include SWOT, Porter’s Five Forces, and PESTEL analysis, with findings cross-validated through robust triangulation for maximum reliability.

Why This RNA-Modified Pseudouridine Report Matters

  • Offers actionable strategies for market entry, supply chain resilience, and technology investment tailored to senior decision-makers.
  • Maps emerging regulatory, trade, and technological dynamics relevant to competitive positioning and risk management.
  • Equips executives with segmentation-based insights and regional perspectives to guide resource allocation and partnership development.

Conclusion

As RNA-modified pseudouridine continues to transform RNA therapeutics and molecular science, this report equips leaders with the insights needed to optimize strategy, capture value, and address challenges in an evolving global market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increase in SARS-CoV-2 mRNA vaccine platforms integrating pseudouridine for immunogenicity enhancement
5.2. Advances in synthetic pseudouridine derivatives improving mRNA stability and translation efficiency profiles
5.3. Regulatory frameworks adapting to approve novel pseudouridine-modified RNA therapeutics with favorable safety outcomes
5.4. Strategic partnerships between biotech companies and academic institutions for high-throughput pseudouridine analog screening
5.5. Scale-up manufacturing innovations driving cost-effective production of pseudouridine nucleoside building blocks globally
5.6. Emergence of lipid nanoparticle delivery systems optimized for pseudouridine-containing mRNA payload targeting specific tissues
5.7. Development of next-generation self-amplifying RNA vaccines leveraging pseudouridine modifications for prolonged antigen expression
5.8. Investment trends focusing on contract development and manufacturing organizations offering specialized pseudouridine RNA synthesis services
5.9. Clinical trial advancements evaluating pseudouridine-modified mRNA therapies in oncology and rare genetic disorder indications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. RNA Modified Pseudouridine Market, by Application
8.1. Introduction
8.2. Academic Research
8.3. Diagnostic Research
8.4. mRNA Therapeutics
8.5. mRNA Vaccines
9. RNA Modified Pseudouridine Market, by Type
9.1. Introduction
9.2. 1-Methylpseudouridine
9.3. Pseudouridine
10. RNA Modified Pseudouridine Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical And Biotechnology Companies
11. RNA Modified Pseudouridine Market, by Form
11.1. Introduction
11.2. Liquid
11.3. Powder
12. RNA Modified Pseudouridine Market, by Purity Grade
12.1. Introduction
12.2. Analytical Grade
12.3. HPLC Grade
13. Americas RNA Modified Pseudouridine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa RNA Modified Pseudouridine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific RNA Modified Pseudouridine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Maravai LifeSciences, Inc.
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. Merck KGaA
16.3.4. Danaher Corporation
16.3.5. Lonza Group AG
16.3.6. New England Biolabs, Inc.
16.3.7. PerkinElmer, Inc.
16.3.8. Bio-Techne Corporation
16.3.9. GenScript Biotech Corporation
16.3.10. Creative Biolabs, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RNA MODIFIED PSEUDOURIDINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RNA MODIFIED PSEUDOURIDINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RNA MODIFIED PSEUDOURIDINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RNA MODIFIED PSEUDOURIDINE MARKET: RESEARCHAI
FIGURE 26. RNA MODIFIED PSEUDOURIDINE MARKET: RESEARCHSTATISTICS
FIGURE 27. RNA MODIFIED PSEUDOURIDINE MARKET: RESEARCHCONTACTS
FIGURE 28. RNA MODIFIED PSEUDOURIDINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RNA MODIFIED PSEUDOURIDINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY DIAGNOSTIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY DIAGNOSTIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY MRNA THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY MRNA THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY MRNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY 1-METHYLPSEUDOURIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY 1-METHYLPSEUDOURIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PSEUDOURIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PSEUDOURIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY ANALYTICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY ANALYTICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY HPLC GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY HPLC GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 69. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 72. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 73. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 76. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 77. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 78. CANADA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 79. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 86. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 87. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 88. MEXICO RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 131. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 134. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 135. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 138. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 139. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 140. GERMANY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 141. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 144. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 145. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 148. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 149. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 150. FRANCE RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 161. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 164. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 165. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 168. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 169. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 170. ITALY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 171. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 174. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 175. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 178. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 179. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 180. SPAIN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 211. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 214. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 215. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 218. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 219. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 220. DENMARK RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 231. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 234. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 235. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 238. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 239. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 240. QATAR RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 241. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 244. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 248. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 249. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 250. FINLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 271. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 274. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 275. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 278. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 279. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 280. EGYPT RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 281. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 284. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 285. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 288. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 289. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 290. TURKEY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 291. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 301. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 304. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 305. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 308. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 309. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 310. NORWAY RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 311. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 314. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 315. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 318. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 319. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 320. POLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 321. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 324. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. ASIA-PACIFIC RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC RNA MODIFIED PSEUDOURIDINE MARKET SIZE, BY TYPE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this RNA Modified Pseudouridine market report include:
  • Maravai LifeSciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group AG
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Bio-Techne Corporation
  • GenScript Biotech Corporation
  • Creative Biolabs, Inc.

Related Reports

Pseudouridine Triphosphate Tetrasodium Salt Solution Market - Global Forecast 2025-2030 - Product Image

Pseudouridine Triphosphate Tetrasodium Salt Solution Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
RNA Modifying Agents Market - Global Forecast 2025-2030 - Product Image

RNA Modifying Agents Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report 2025 - Product Image

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report 2025

  • Report
  • 250 Pages
  • Global
From
m-RNA Synthesis Services - Global Strategic Business Report - Product Image

m-RNA Synthesis Services - Global Strategic Business Report

  • Report
  • 227 Pages
  • Global
From
Phosphoramidite - Global Strategic Business Report - Product Image

Phosphoramidite - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.